drugset / Trial / NCT02261025

The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis

NCT02261025

Non-randomizedParallel-groupOpen-labelPrevention

Summary

The aim of present study is to examine the effect of low-dose aspirin on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis.

Timeline

Start
2008-01
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 75 mg Oral
Subject Aspirin Small molecule 100 mg Oral

Indications

No indication recorded.